ClinicalTrials.Veeva

Menu

Improving Venous Thromboembolism Prophylaxis

Mayo Clinic logo

Mayo Clinic

Status and phase

Completed
Phase 4

Conditions

Quality Improvement
Delivery of Health Care
Venous Thromboembolism

Treatments

Other: BLAZE Pop up
Other: Usual Care
Other: VTE-P Tollgate

Study type

Interventional

Funder types

Other

Identifiers

NCT01304108
09-006359

Details and patient eligibility

About

Preventing the formation of blood clots in the veins so they do not injure leg veins or travel to the lungs, also called venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including The investigators own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for "spreading" to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%.

Full description

Venous thromboembolism prophylaxis (VTE-P) is an essential component of safe in-patient care, yet it is deployed sub-optimally in many hospitals, including our own. Two prior VTE-P improvement projects were completed at Mayo Clinic hospitals, one in the Department of Medicine, and the other in selected divisions of the Department of Surgery. Both projects resulted in marked improvement in the percentage of patients receiving appropriate VTE-P. This project seeks to utilize the lessons learned from these two pilots along with known best practices for "spreading" to deploy methods that enhance VTE-P to the entire hospitalized population. The investigators seek appropriate VTE-P rates exceeding 95%. This began as a quality improvement project. The investigators have taken baseline measures of VTE-P rates in our hospitals, intervened with various electronic prompts to use appropriate VTE-P, and have and will re-measure VTE-P rates. The investigators intend to present and publish our methods and results so that lessons learned may be shared and applied elsewhere.

Enrollment

3,000 patients

Sex

All

Ages

17+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Inpatients with age > 17 years old

Exclusion criteria

  • Outpatients
  • Inpatients with age less than or equal to 17 years old

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

3,000 participants in 3 patient groups

Order Set
Experimental group
Description:
Insertion of VTE-P Order Set "tollgate" in all active admission and transfer orders.
Treatment:
Other: VTE-P Tollgate
Clinical Decision Support Pop-up
Experimental group
Description:
Deploy rules-based pop-up that reminds ordering clinicians when patients do not have an active VTE-P plan.
Treatment:
Other: BLAZE Pop up
Usual Care
Active Comparator group
Description:
Usual care, without the experimental additions
Treatment:
Other: Usual Care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems